{"disease":{"id":"everolimus","name":"everolimus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03730428","title":"Everolimus Related Pneumonitis in MBC","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT03014297","title":"Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"Lowell Anthony, MD","has_results":false},{"nct_id":"NCT05054166","title":"Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}